Haff disease: overview and clinical features
- PMID: 39258655
- PMCID: PMC11385071
- DOI: 10.1590/S1678-9946202466052
Haff disease: overview and clinical features
Abstract
Haff disease was first described at the beginning of the twentieth century in Europe. Almost a century later, thousands of cases have now been reported in different countries. In Brazil, most cases are observed in the Amazon region, and its associated factors remain to be fully understood. This disease is an uncommon syndrome characterized by intense myalgia and rhabdomyolysis, which manifests within 24 h after consuming some types of freshwater or saltwater fish and crustaceans. A possible heat-stable toxin contained in seafood may be the cause of Haff disease, but this hypothesis is not yet completely proven. This review will describe the clinical and epidemiological aspects of Haff disease with updated literature.
Conflict of interest statement
CONFLICT OF INTERESTS
The research was conducted in the absence of any commercial or financial relationships that could be a potential conflict of interests.
Figures
References
-
- Stanley M, Chippa V, Aeddula NR, Quintanilla Rodriguez BS. Rhabdomyolysis. [cited 2024 May 20]. https://www.statpearls.com/point-of-care/28509#:~:text=Rhabdomyolysis%20... - PubMed
-
- Diaz JH. Global incidence of rhabdomyolysis after cooked seafood consumption (Haff disease) Clin Toxicol (Phila) 2015;53:421–426. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources